TD Cowen Maintains Hold on Legend Biotech, Lowers Price Target to $24

Benzinga Newsdesk www.benzinga.com Negative 80.9%

Neg 80.9% Neu 0% Pos 0%

TD Cowen analyst Yaron Werber maintains Legend Biotech (NASDAQ:LEGN) with a Hold and lowers the price target from $29 to $24.